BioMedNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Launches Upgraded MedOfficeDirect Platform on Shopify

HealthLynked (OTCQB: HLYK), a leading provider of healthcare technology and patient engagement solutions, announced the launch of its new MedOfficeDirect e-commerce platform, now live at DiscountOnlineMedicalSupplies.com and built on Shopify. The upgraded platform delivers faster performance, enhanced security, and a modern checkout experience while offering an average 20% price reduction across its catalog of brand-name medical supplies. HealthLynked plans to expand the curated inventory and, upon completing its marketing and backend transition, migrate the platform back to MedOfficeDirect.com. CEO Dr. Michael Dent said the launch represents a major step forward in accessibility and scalability, enabling patients and healthcare providers to purchase essential products through a faster, more reliable system.

To view the full press release, visit https://ibn.fm/deMzj

About HealthLynked Corp.

HealthLynked Corp. is transforming healthcare by connecting patients and providers through a secure, cloud-based network. The company’s platform consolidates medical records, offers AI-driven care guidance, enables appointment booking and telemedicine, and supports a growing ecosystem of healthcare products and services.

NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYLK

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Issues Shareholder Letter Outlining Strategic Review and Focus on TPI 287

CNS Pharmaceuticals (NASDAQ: CNSP) released a Letter to Shareholders from newly appointed President and Chief…

22 hours ago

BioMedNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Engages IBN for Corporate Communications Support

Earth Science Tech (OTC: ETST), a strategic holding company advancing a portfolio of operating businesses…

5 days ago

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer 

HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care through actionable cardiac insights,…

6 days ago

BioMedNewsBreaks — Oncotelic Therapeutics Inc.’s (OTLC) Deciparticle(TM) Platform Expands Possibilities in Immunology and Oncology

Oncotelic Therapeutics (OTCQB: OTLC) is rapidly emerging in next-generation drug delivery, with a scalable nanotechnology platform…

7 days ago

BioMedNewsBreaks — Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) to Participate In DealFlow Discovery Conference

Lixte Biotechnology Holdings (NASDAQ: LIXT) announced it will participate in the DealFlow Discovery Conference to be held Jan. 28–29, 2026, in Atlantic…

1 week ago

BioMedNewsBreaks — Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF) (FWB: 4D4A) Engages IBN for Corporate Communications and Awareness

Disseminated on behalf of Diagnos Inc. and may include paid advertising.  Diagnos (TSX Venture: ADK) (OTCQB: DGNOF) (FWB: 4D4A), a pioneer in early detection…

2 weeks ago